Action ENGN ENGENE HOLDINGS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués enGene Holdings Inc.

Actions

ENGN

CA29286M1059

Cours en clôture Nasdaq
Autres places de cotation
 00:00:00 26/06/2024 		Varia. 5j. Varia. 1 janv.
8 USD -1,23% Graphique intraday de enGene Holdings Inc. -4,31% -13,33%
14/06 EnGene Holdings Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 avril 2024 CI
15/05 EnGene Holdings Inc. approuve les nominations au conseil d'administration CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
EnGene Reports Second Quarter 2024 Financial Results and Provides a Business Update
AQ
EnGene Reports Second Quarter 2024 Financial Results and Provides a Business Update
BU
EnGene to Present at the Jefferies Global Healthcare Conference
BU
EnGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors
BU
EnGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting
AQ
EnGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development
AQ
/C O R R E C T I O N -- enGene Inc./
AQ
EnGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
PR
EnGene : Reports First Quarter 2024 Financial Results and Recent Corporate Progress - Form 8-K
PU
EnGene To Present at the Leerink Partners Global Biopharma Conference
PR
EnGene Announces Oversubscribed $200 Million Private Placement Financing
PR
EnGene Announces Leadership Succession Plan
PR
EnGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary
PR
EnGene Reports Full Year 2023 Financial Results and Recent Operational Progress
PR
EnGene Appoints Lota S. Zoth, CPA, as Member of the Board of Directors
PR
EnGene Appoints Ryan Daws as Chief Financial Officer
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ENGN
  4. Actualités enGene Holdings Inc.
  5. Communiqués